CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013	Dec. 31, 2012
Cash flows from operating activities:
Net loss	$ (53,594)	$ (6,989)	$ (413)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation	20,856	837	12
Amortization of intangibles	19,531	1,275	9
Amortization of deferred financing costs	3,753	250	1
Amortization of mortgage premium	(498)	(1)	0
Accretion of below-market lease liability	(1,085)	(29)	0
Amortization of above-market lease assets	1,085	0	9
Amortization of above-market ground lease assets	32	0	0
Share-based compensation	106	24	11
Net realized and unrealized mark-to-market transactions	(3,272)	0	0
Changes in assets and liabilities:
Prepaid expenses and other assets	(20,644)	(1,819)	(76)
Deferred tax asset	(2,102)	0	0
Due from affiliates	0	0	0
Accounts payable and accrued expenses	15,749	1,888	29
Deferred rent	10,390	917	0
Net cash used in operating activities	(9,693)	(3,647)	(418)
Cash flows from investing activities:
Investment in real estate and other assets	(1,507,072)	(110,026)	(1,357)
Deposits for real estate acquisitions	(775)	(1,474)	0
Capital expenditures	(8,838)	0	0
Purchase of investment securities	(490)	0	0
Net cash used in investing activities	(1,517,175)	(111,500)	(1,357)
Cash flows from financing activities:
Borrowings under credit facility	258,500	0	0
Repayments on credit facility	(18,500)	0	0
Proceeds from notes payable	12,505	0	0
Payments on notes payable	(12,505)	0	0
Payments on mortgage notes payable	(135)	0	0
Proceeds from issuance of common stock	1,569,082	148,871	2,031
Payments of offering costs	(168,270)	(18,770)	(748)
Payments of deferred financing costs	(16,888)	(2,345)	(41)
Distributions paid	(35,415)	(1,769)	(1)
Advances from affiliates, net	(100)	(1,041)	786
Restricted cash	(5,367)	(737)	0
Net cash provided by financing activities	1,582,907	124,209	2,027
Net change in cash and cash equivalents	56,039	9,062	252
Effect of exchange rate on cash	(2,855)	2,176	10
Cash and cash equivalents, beginning of period	11,500	262	0
Cash and cash equivalents, end of period	64,684	11,500	262
Supplemental Disclosures
Cash paid for interest	6,540	218	0
Non-Cash Investing and Financing Activities:
Mortgage notes payable assumed or used to acquire investments in real estate	217,791	75,651	1,228
Premium on mortgage note payable	0	1,664	0
Borrowings under line of credit to acquire real estate	446,558	0	0
Common stock issued through distribution reimbursement plan	44,886	1,320	0
Reclassification of deferred offering costs	$ 0	$ 0	$ 559